Knee Osteoarthritis
Conditions
Keywords
lateral wedge inserts, shoe inserts
Brief summary
This trial will assess the ability of shoe inserts to relieve pain and disability in people with knee osteoarthritis (OA) in the inner (medial) aspect of the knee.
Detailed description
Osteoarthritis (OA), the most common joint disease in humans, is a significant cause of pain and disability. Its prevalence increases with age, leading to about 65-85% of those age 65 years and older having OA. Involvement of the knee with OA is the main reason for significant functional impairment as it alters ambulation through pain and stiffness. Nonpharmacological management of knee OA includes the use of orthotic supports such as wedged insoles for varus or valgus knee deformities to relieve pain and improve function in the early stages of this joint disease. Although these interventions are desirable because they are simple and inexpensive, we do not have a clear understanding about their efficacy in relieving pain and disability in people with knee OA. We also do not know whether there is a relationship between changes in joint biomechanics that occur with wedged insoles and changes in function and progression of OA. Furthermore, information is lacking regarding which patients would benefit from wedged insoles. Answering these questions will be critically important in the development of guidelines for the prescription of wedged insoles in knee OA. Patients in this study will be evaluated at baseline and after wearing the lateral-wedged insoles immediately and after wearing the insoles for four weeks. The participants will wear lateral-wedged insoles for the painful knee(s) for as many hours and for as many days of the week as they can tolerate. Some subjects may use a neutral position insole for an asymptomatic knee.
Interventions
DEVICEShoe insert
Subjects with knee OA underwent gait analysis and knee pain and function assessment at baseline while wearing walking shoes and after four weeks of wearing walking shoes with lateral-wedged insoles.
OTHERwalking shoes
walking shoes
Sponsors
VA Office of Research and Development
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
45 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Ability to walk 30 feet without a walking aid * Ability to stand unaided * Ability to understand verbal instructions * Ability to give informed consent
Exclusion criteria
* History of knee trauma or surgery including arthroscopic surgery in the past 6 months * Severe obesity (\>30 kg/m2) * Neurological disease * Injury or amputation to the lower extremity joints * History of other types of arthritis * Symptomatic spine, hip, ankle, or foot disease that would interfere with assessment of the knee * Intra-articular steroids in the past 3 months, or hyaluronic acid in the last 6 months * Poor health that would impair compliance or assessment such as shortness of breath with exertion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC pain scale | 6 months |
Countries
United States
Outcome results
None listed